Perci Health secures £1.1m seed funding for virtual cancer clinic platform

London-based Perci Health has raised an estimated £1.1m in its latest seed funding round. The investment brings the virtual cancer clinic platform to a post-money valuation of approximately £19.4m.

Founded in 2020, the company operates a digital healthcare platform that connects individuals living with or beyond cancer, as well as their caregivers, to a multidisciplinary network of vetted specialists. The network includes oncology nurses, dietitians, physiotherapists, psychologists, and sexual medicine practitioners who provide personalised support, rehabilitation, and survivorship care. Perci Health offers these services directly to consumers and through partnerships with employers and insurers who integrate the platform into employee benefit and insurance packages.

This funding round (filed in March 2026) follows a period of frequent capital raises for the startup. In April 2025, the company secured £772.3k, which followed a £214k round in March 2025. During February 2025, Perci Health completed several seed allotments including sums of £1m, £295k, £226.8k, and £26.8k. Earlier activity in late 2024 included rounds of £112.5k in November and two December allotments of £67.4k and £30k.

The company is headquartered in London and currently lists 20 employees in its latest accounts, though LinkedIn data suggests a larger workforce of 55 people. In March 2026, the company appointed Guy David Reynolds to its board of directors. LinkedIn profiles suggest Reynolds may be a warehouse associate at Waitrose and Partners, though this professional link is unverified.

Perci Health provides a single destination for tailored answers and access to high-quality cancer professionals. The platform is built to help users navigate long-term healthcare needs and manage their wellbeing throughout the cancer journey.